A disruptive technology to tackle brain cancer and glioblastoma
News
May 12. 2017: the first ever patient treated with Hemerion technology
Five years ago, on May, 12th 2017, Pr. Nicolas Reyns delivered, for the first time ever, the therapy currently being developed by Hemerion. It was the first time that this… ...
Hemerion raises €3.5 million to develop new solutions for the treatment of glioblastoma
One year after the first round of funding, Hemerion's new €3.55 million financing will accelerate the implementation of international clinical trials for the treatment of glioblastoma, the most aggressive brain… ...
Mission to Boston: Hemerion prepares its development in the United States
Presentation of the Hemerion technology, meeting with investors, neurosurgeons and care centers, discussions about North American regulations: Hemerion has set new milestones for its international development during a 5-day mission… ...
Stay tuned to our clinical advances